Sulfasalazine: Overview and Core Content

Sulfasalazine is a sulfonamide synthetic drug with both antibacterial and anti-inflammatory effects. It is mainly used to treat autoimmune diseases such as ulcerative colitis and rheumatoid arthritis. Its core mechanism is to decompose it into the active ingredients 5-aminosalicylic acid and sulfapyridine through the intestinal tract, which exerts local anti-inflammatory and immunomodulatory effects. This article will start from the drug characteristics, clinical applications, manufacturers and precautions, focusing on analyzing its efficacy and safety.

Drug properties and mechanism of action

Sulfasalazine is unique in that itprodrug design, after oral administration, it is decomposed by intestinal bacteria into 5-aminosalicylic acid (directly acts on intestinal inflammation) and sulfapyridine (suppresses immune response). This dual action makes it a first-line option for mild to moderate ulcerative colitis. Research shows that it is 60%-70% effective in relieving joint swelling and pain in rheumatoid arthritis (New England Journal of Medicine). It should be noted that its efficacy is dose-related, but you need to be alert to possible allergic reactions caused by the sulfonamide ingredients.

Clinical applications and indications

The clinical application of sulfasalazineChronic disease managementLord. In ulcerative colitis, it can significantly reduce the recurrence rate; for rheumatoid arthritis, it is often combined with methotrexate to enhance the efficacy. Clinical trials have shown that after 12 weeks of continuous use, the intestinal mucosal healing rate of patients increased by approximately 40% (The Lancet Gastroenterology Sub-Journal). However, it is contraindicated in late pregnancy and those with sulfonamide allergy. Long-term use requires monitoring of liver and kidney function and blood routine.

Manufacturer and dosage form information

Summary and Notes

As a classic immunomodulatory drug, sulfasalazine is effective but needs to be used in a standardized manner. Patients should adjust the dosage as directed by their doctor and pay attention to replenishing fluids to reduce the risk of crystalluria. Its price is affordable (the average daily cost is about 5-10 yuan), but gastrointestinal side effects are common, so it is recommended to take it after meals. Future research may explore its potential for combined use with other biological agents.

Citing sources

1. "New England Journal of Medicine": Randomized controlled trial of sulfasalazine in the treatment of rheumatoid arthritis (2018)
2. The Lancet Gastroenterology: Meta-analysis of drug efficacy in ulcerative colitis (2020)
3. National Medical Products Administration: Instructions for Sulfasalazine Tablets (2022 Edition)